Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke Bernard TJ; Manco-Johnson MJ; Goldenberg NAThromb Res 2011[Jan]; 127 (1): 6-12Childhood-onset arterial ischemic stroke (AIS) is a rare disorder with high risks of both recurrent stroke and life-long neurological morbidity. Anatomic risk factors for primary and/or recurrent AIS include a venous thrombotic source for paradoxical embolism via a patent foramen ovale, primary cardioembolism, extracranial dissection, and intracranial arteriopathies, among others. Genetic and acquired thrombophilias are common, some of which have been shown to have prognostic influence on risk of recurrent AIS. While knowledge of childhood AIS risk factors has grown considerably in recent years, an evidence-based understanding of optimal antithrombotic therapy strategies has not yet been attained. Consensus-based guidelines have been developed, but future research must emphasize identification of additional prognostic factors and the initiation of cooperative randomized controlled clinical trials.|Adolescent[MESH]|Age of Onset[MESH]|Brain Ischemia/blood/etiology/*prevention & control[MESH]|Cerebral Arterial Diseases/blood/*drug therapy/etiology[MESH]|Child[MESH]|Child, Preschool[MESH]|Evidence-Based Medicine[MESH]|Fibrinolytic Agents/*therapeutic use[MESH]|Humans[MESH]|Infant[MESH]|Infant, Newborn[MESH]|Recurrence[MESH]|Risk Factors[MESH]|Stroke/blood/etiology/*prevention & control/therapy[MESH]|Thromboembolism/blood/*drug therapy/etiology[MESH]|Thrombophilia/blood/complications/*drug therapy[MESH]|Treatment Outcome[MESH] |
